AERIE PHARMACEUTICALS INC Annual Depreciation in USD from 2011 to 2021

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Depreciation history and growth rate from 2011 to 2021.
  • Aerie Pharmaceuticals Inc Depreciation for the quarter ending March 31, 2022 was $1.6M, a 7.01% increase year-over-year.
  • Aerie Pharmaceuticals Inc annual Depreciation for 2021 was $6.4M, a 0.52% increase from 2020.
  • Aerie Pharmaceuticals Inc annual Depreciation for 2020 was $6.37M, a 23.9% increase from 2019.
  • Aerie Pharmaceuticals Inc annual Depreciation for 2019 was $5.14M, a 110% increase from 2018.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $6.4M +$33K +0.52% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-25
2020 $6.37M +$1.23M +23.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 $5.14M +$2.7M +110% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $2.44M +$1.03M +73.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $1.41M +$440K +45.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $970K +$718K +285% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $252K +$179K +245% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $73K +$9K +14.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $64K -$74K -53.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-02
2012 $138K +$18K +15% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $120K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.